Study Summary
This trial is testing a new way to treat high risk prostate cancer that may be more effective than current methods.
- Prostate Cancer
- Advanced Prostate Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: At 36 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
First Strike then Second Strike
1 of 1
Experimental Treatment
31 Total Participants · 1 Treatment Group
Primary Treatment: Luteinizing Hormone Releasing Hormone · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What studies have been conducted using Luteinizing Hormone Releasing Hormone as an intervention?
"Presently, 643 trials are investigating the effects of Luteinizing Hormone Releasing Hormone. 209 of those clinical studies are Phase 3 and are concentrated in Germantown, Tennessee; however, there exist 38,624 locations that offer this treatment option." - Anonymous Online Contributor
How many participants are enrolled in this trial to its fullest extent?
"Affirmative. According to the information available on clinicaltrials.gov, this medical trial is currently recruiting patients - it was initially posted on January 25th 2022 and its most recent update came through November 28th 2022. It seeks 31 participants from a single medical centre." - Anonymous Online Contributor
To what afflictions is Luteinizing Hormone Releasing Hormone typically administered?
"Luteinizing Hormone Releasing Hormone is usually employed to combat malignant neoplasms, yet its efficacy can also be observed in therapeutic procedures, hypogonadotropic ovarian failure and sarcoma." - Anonymous Online Contributor
What is the federal regulatory stance on Luteinizing Hormone Releasing Hormone?
"Our team at Power rated Luteinizing Hormone Releasing Hormone with a score of 2. This is due to the medication being in Phase 2, meaning that it has some safety data but there are no efficacy studies yet conducted." - Anonymous Online Contributor
Are there any vacancies for participants in this trial?
"Affirmative, the information archived on clinicaltrials.gov suggests that this experiment is currently enlisting volunteers. The trial was inaugurated on January 25th 2022 and its most recent update occurred November 28th 2022 - with a total of 31 participants being sought from one site." - Anonymous Online Contributor